- Joined
- Feb 24, 2012
- Messages
- 167
- Reaction score
- 18
We all know medicine is a continually evolving field. And even when a change in the standard of care occurs, we tend to be forgiving for a little while during the transition time, when some people may hang on to the old ways for a bit.
But when it starts to interfere in testing, such as the RISE and various board exams, I get really ticked. 😡
The new recommendation is to call eosinophilic esophagitis if you see just 15 eos per HPF instead of 20? Okay, fine. But if you have a test question on that a full year after this is publicly announced, don't ding my answer as wrong if I call EE when there are 17 eos in the image.
We've moved to a full, standardized Bethesda system on Paps, and calling adenocarcinoma in situ from a Pap is no longer deemed appropriate? Fine, but then don't have adenocarcinoma in situ as the correct answer to a test question.
The proper follow-up for LSIL is colposcopy? Great. But why have that as an "official" stance and as a test question if the majority of clinicians actually just do repeat Pap in 6-12 months?
Writing letters or emails to those who have a monopoly on writing the exams is useless. I've even spoken face-to-face to some of the AP board organizers at a national conference on this issue, and was not encouraged by their replies (basically, they admitted they are out of the loop and so it may take up to 5 years for current, proper practice answers to make it into the exams).
So what are we to do? Learn both the real and outdated info for everything, and just hope we remember which data to use on a test versus which to use in real life?
Grr. Not likely to find an answer here, but I think it's worth chewing the fat over.
But when it starts to interfere in testing, such as the RISE and various board exams, I get really ticked. 😡
The new recommendation is to call eosinophilic esophagitis if you see just 15 eos per HPF instead of 20? Okay, fine. But if you have a test question on that a full year after this is publicly announced, don't ding my answer as wrong if I call EE when there are 17 eos in the image.
We've moved to a full, standardized Bethesda system on Paps, and calling adenocarcinoma in situ from a Pap is no longer deemed appropriate? Fine, but then don't have adenocarcinoma in situ as the correct answer to a test question.
The proper follow-up for LSIL is colposcopy? Great. But why have that as an "official" stance and as a test question if the majority of clinicians actually just do repeat Pap in 6-12 months?
Writing letters or emails to those who have a monopoly on writing the exams is useless. I've even spoken face-to-face to some of the AP board organizers at a national conference on this issue, and was not encouraged by their replies (basically, they admitted they are out of the loop and so it may take up to 5 years for current, proper practice answers to make it into the exams).
So what are we to do? Learn both the real and outdated info for everything, and just hope we remember which data to use on a test versus which to use in real life?
Grr. Not likely to find an answer here, but I think it's worth chewing the fat over.